MoonLake Immunotherapeutics (MLTX)
43.67
-0.85
(-1.91%)
USD |
NASDAQ |
May 07, 16:00
43.75
+0.08
(+0.18%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Return Price: 43.67 for May 7, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 07, 2024 | 43.67 |
| May 06, 2024 | 44.52 |
| May 03, 2024 | 45.26 |
| May 02, 2024 | 42.57 |
| May 01, 2024 | 42.84 |
| April 30, 2024 | 40.91 |
| April 29, 2024 | 41.77 |
| April 26, 2024 | 42.49 |
| April 25, 2024 | 42.25 |
| April 24, 2024 | 42.43 |
| April 23, 2024 | 43.25 |
| April 22, 2024 | 41.02 |
| April 19, 2024 | 42.19 |
| April 18, 2024 | 42.25 |
| April 17, 2024 | 43.51 |
| April 16, 2024 | 43.50 |
| April 15, 2024 | 43.64 |
| April 12, 2024 | 43.91 |
| April 11, 2024 | 45.65 |
| April 10, 2024 | 46.18 |
| April 09, 2024 | 46.75 |
| April 08, 2024 | 46.27 |
| April 05, 2024 | 47.17 |
| April 04, 2024 | 45.99 |
| April 03, 2024 | 45.97 |
| Date | Value |
|---|---|
| April 02, 2024 | 47.25 |
| April 01, 2024 | 48.60 |
| March 28, 2024 | 50.23 |
| March 27, 2024 | 50.21 |
| March 26, 2024 | 50.08 |
| March 25, 2024 | 51.74 |
| March 22, 2024 | 52.00 |
| March 21, 2024 | 52.37 |
| March 20, 2024 | 49.50 |
| March 19, 2024 | 50.59 |
| March 18, 2024 | 48.56 |
| March 15, 2024 | 47.25 |
| March 14, 2024 | 43.78 |
| March 13, 2024 | 44.90 |
| March 12, 2024 | 46.04 |
| March 11, 2024 | 47.05 |
| March 08, 2024 | 45.61 |
| March 07, 2024 | 45.58 |
| March 06, 2024 | 45.21 |
| March 05, 2024 | 48.10 |
| March 04, 2024 | 48.86 |
| March 01, 2024 | 50.92 |
| February 29, 2024 | 48.24 |
| February 28, 2024 | 56.81 |
| February 27, 2024 | 54.76 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
4.69
Minimum
May 16 2022
63.86
Maximum
Feb 12 2024
21.39
Average
10.33
Median
Jun 21 2021
Total Return Price Benchmarks
| Qiagen NV | 42.95 |
| LENZ Therapeutics Inc | 16.43 |
| AC Immune SA | 2.38 |
| CRISPR Therapeutics AG | 55.56 |
| Addex Therapeutics Ltd | 9.15 |